Efficacy and safety of radiofrequency ablation for secondary hyperparathyroidism: a systematic review and meta-analysis
2024

Radiofrequency Ablation for Secondary Hyperparathyroidism

Sample size: 118 publication Evidence: moderate

Author Information

Author(s): Mengyuan Li, Hongwei Jiang, Yunchang Wang, Fujun Li

Primary Institution: The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology

Hypothesis

Is radiofrequency ablation (RFA) an effective and low-risk treatment for hyperparathyroidism secondary to chronic kidney disease (CKD)?

Conclusion

RFA is an effective and safe treatment for hyperparathyroidism secondary to CKD, with hoarseness being the most common complication that typically resolves within 6 months.

Supporting Evidence

  • Serum PTH levels decreased significantly after RFA at 1 day, 6 months, and 12 months.
  • Serum calcium levels also showed significant reduction after RFA.
  • Serum phosphorus levels decreased significantly at 1 day and 6 months post-RFA.
  • Hoarseness was reported as the most common complication but resolved within 6 months.

Takeaway

Radiofrequency ablation is like using heat to help fix a problem with a gland in your neck that can make you feel sick if it works too hard. It helps people feel better without needing big surgery.

Methodology

The study involved a systematic review and meta-analysis of four retrospective studies comparing biochemical indicators before and after RFA.

Potential Biases

Potential bias due to the exclusion of randomized controlled trials and the retrospective nature of the included studies.

Limitations

The study only included retrospective studies from China, which may limit the generalizability of the findings.

Participant Demographics

The studies included a total of 118 patients with secondary hyperparathyroidism, with a mean age around 51 years.

Statistical Information

P-Value

p<0.0001

Confidence Interval

95% CI = from −3.52 to −1.17

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.2478/abm-2024-0036

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication